A biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders, including depression, migraine, and sleep-related conditions. Its portfolio includes approved treatments such as Auvelity for major depressive disorder and Sunosi for excessive...
1 member of Congress has disclosed 1 trade in Axsome Therapeutics, Inc. (AXSM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |